Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

SANDOZ INC

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 36
  • 0 comments

FDA approve CISATRACURIUM BESYLATE

Comment Full text

AUROBINDO PHARMA

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 38
  • 0 comments

FDA approve LEVETIRACETAM

Comment Full text

UNICHEM

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 46
  • 0 comments

FDA approve TOLTERODINE TARTRATE

Comment Full text

AMPHASTAR PHARM

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 41
  • 0 comments

FDA approve HYALURONIDASE

Comment Full text

ACTAVIS INC

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 39
  • 0 comments

FDA approve DOXORUBICIN HYDROCHLORIDE

Comment Full text

MEITHEAL

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 41
  • 0 comments

FDA approve DESMOPRESSIN ACETATE

Comment Full text

MYLAN PHARMS INC

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 40
  • 0 comments

FDA approve LITHIUM CARBONATE

Comment Full text

DR REDDYS

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 37
  • 0 comments

FDA approve FESOTERODINE FUMARATE

Comment Full text

GLAND PHARMA LTD

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 42
  • 0 comments

FDA approve DOXORUBICIN HYDROCHLORIDE

Comment Full text

EPIC PHARMA LLC

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 38
  • 0 comments

FDA approve DOXEPIN HYDROCHLORIDE

Comment Full text
  • Previous
  • 363
  • 364
  • 365
  • 366
  • 367
  • Next

Search

News categories

  • Technical Exchange News(11504)
  • Event(3374)
  • SEC News(216359)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(137580)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin